You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

Claims for Patent: 7,560,120

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 7,560,120

Title:	Vehicles for delivery of biologically active substances
Abstract:	A formulation containing one or more biologically active substances dissolved, dispersed, emulsified, or suspended within a vehicle of one or more citric acid esters and/or citric acid ethers. Methods for making and using are disclosed, as are kits for administration of the pharmaceutical formulation.
Inventor(s):	Shukla; Atul J. (Cordova, TN), Johnson; James R. (Germantown, TN), Sun; Yichun (Germantown, TN), Cooper; Robert (Starkville, MS), Boring; Gregg (Starkville, MS), Scruggs; Dan (Starkville, MS)
Assignee:	University of Tennessee Research Foundation (Knoxville, TN)
Application Number:	11/194,885
Patent Claims:	1. A composition comprising a biologically active substance (BAS) and a citric acid ester (CAE) and/or a citric acid ether, wherein the amount of the CAE and/or the ether in the composition is sufficient to dissolve, disperse, emulsify, or suspend the entire amount of the BAS in the composition, and the BAS in the composition is dissolved, dispersed, emulsified, or suspended in the citric acid ester or ether wherein the CAE and/or the citric acid ether is present in the composition in a concentration higher than that of any other constituent of the composition. 2. The composition of claim 1 wherein the CAE is selected from the group consisting of triethyl citrate, acetyl triethyl citrate, tri-n-butyl citrate, acetyl tri-n-butyl citrate, acetyl tri-n-hexyl citrate, and butyryl tri-n-hexyl citrate. 3. The composition of claim 1 wherein the composition comprises a multiplicity of different CAEs and/or citric acid ethers. 4. The composition of claim 1 which frrther contains a polymer, 5. The composition of claim 1 wherein the concentration of the CAE and the citric acid ether in the composition is greater than 3% w/w. 6. The composition of claim 5 wherein the concentration of the CAE and the citric acid ether in the composition is greater than 10% w/w. 7. The composition of claim 6 wherein the concentration of the CAE and the citric acid ether in the composition is greater than 25% w/w. 8. The composition of claim 7 wherein the concentration of the CAE and the citric acid ether in the composition is greater than 50% w/w. 9. The composition of claim 1 which further contains a gelling agent 10. The composition of claim 1 which is a liquid. 11. The composition of claim 1 which is a semi-solid, a gel, a paste, or a solid. 12. The composition of claim 1 wherein the CAE or citric acid ether is hydrophobic. 13. The composition of claim 1 wherein the CAE or citric acid ether is hydrophilic. 14. The composition of claim 1 which further comprises a wax.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.